X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-02-02 | ALXO | Alx Oncology Holdings Inc | Goodman Corey S | Dir, 10% | P - Purchase | $1.57 | +3,184,713 | 13,052,008 | +32% | +$4,999,999 | ||||||
2026-01-28 | ANIX | Anixa Biosciences Inc | Baskies Arnold M | Dir | P - Purchase | $3.04 | +10,000 | 135,000 | +8% | +$30,400 | ||||||
| D | 2026-01-30 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO | P - Purchase | $0.89 | +28,100 | 375,520 | +8% | +$25,009 | |||||
| M | 2026-02-18 | ARAY | Accuray Inc | Mayer Steven F | Dir | P - Purchase | $0.53 | +195,125 | 1,490,745 | +15% | +$103,797 | |||||
| M | 2026-02-17 | BLIN | Bridgeline Digital, Inc. | Kahn Roger E. | Pres, CEO, 10% | P - Purchase | $0.78 | +54,301 | 1,764,280 | +3% | +$42,206 | |||||
2026-02-13 | CHGG | Chegg, Inc | Rosensweig Daniel | Pres, CEO, EXEC COB | P - Purchase | $0.56 | +100,000 | 7,674,917 | +1% | +$56,360 | ||||||
2026-02-13 | CHUC | Charlie'S Holdings, Inc. | Carmines Edward | Dir | P - Purchase | $0.20 | +250,000 | 2,256,481 | +12% | +$50,000 | ||||||
2026-02-13 | CHUC | Charlie'S Holdings, Inc. | King Michael D | Dir | P - Purchase | $0.20 | +500,000 | 6,750,001 | +8% | +$100,000 | ||||||
2026-02-13 | CHUC | Charlie'S Holdings, Inc. | Montesano Matthew P | CFO | P - Purchase | $0.20 | +100,000 | 2,825,409 | +4% | +$20,000 | ||||||
2026-02-13 | CHUC | Charlie'S Holdings, Inc. | Sicignano Henry III | Pres | P - Purchase | $0.20 | +250,000 | 9,950,001 | +3% | +$50,000 | ||||||
2026-02-13 | CHUC | Charlie'S Holdings, Inc. | Stump Ryan | COO | P - Purchase | $0.20 | +250,000 | 29,701,755 | +1% | +$50,000 | ||||||
2026-02-17 | CMRC | Commerce.Com, Inc. | Siminoff Ellen F | Exec Chair | P - Purchase | $2.94 | +100,000 | 431,319 | +30% | +$294,080 | ||||||
2026-02-19 | CNDT | Conduent Inc | Fucci Michael | Dir | P - Purchase | $1.44 | +60,000 | 166,102 | +57% | +$86,580 | ||||||
2026-02-18 | CNDT | Conduent Inc | Palau Hernandez Margarita | Dir | P - Purchase | $1.45 | +50,000 | 452,996 | +12% | +$72,650 | ||||||
| M | 2026-02-18 | CNDT | Conduent Inc | Agadi Harshavardhan V | CEO | P - Purchase | $1.43 | +220,000 | 2,116,829 | +12% | +$313,720 | |||||
| D | 2026-02-17 | CNVS | Cineverse Corp. | McGurk Christopher J | CEO, COB | P - Purchase | $2.00 | +75,000 | 671,045 | +13% | +$150,000 | |||||
| D | 2026-02-17 | CNVS | Cineverse Corp. | Loffredo Gary S | CLO, Secretary, Sr Advisor | P - Purchase | $2.00 | +30,000 | 200,337 | +18% | +$60,000 | |||||
| D | 2026-02-17 | CNVS | Cineverse Corp. | Opeka Erick | CSO, Pres | P - Purchase | $2.00 | +30,000 | 224,146 | +15% | +$60,000 | |||||
| D | 2026-02-17 | CNVS | Cineverse Corp. | Macias Yolanda | Chief Motion Pictures Officer | P - Purchase | $2.00 | +30,000 | 121,906 | +33% | +$60,000 | |||||
| D | 2026-02-17 | CNVS | Cineverse Corp. | Torres Mark | Chief People Officer | P - Purchase | $2.00 | +25,000 | 183,274 | +16% | +$50,000 | |||||
| D | 2026-02-17 | CNVS | Cineverse Corp. | Lindsey Mark Wayne | CFO | P - Purchase | $2.00 | +35,000 | 154,168 | +29% | +$70,000 | |||||
| D | 2026-02-17 | CNVS | Cineverse Corp. | Huidor Mark Antonio | Pres Tech, Chief Product Off | P - Purchase | $2.00 | +37,500 | 190,061 | +25% | +$75,000 | |||||
| D | 2026-02-12 | COCH | Envoy Medical, Inc. | Taylor Glen A | 10% | P - Purchase | $0.40 | +18,750,000 | 29,040,049 | +182% | +$7,500,000 | |||||
| D | 2026-02-12 | COCH | Envoy Medical, Inc. | Brynelsen Charles | Dir | P - Purchase | $0.40 | +1,000,000 | 1,050,000 | >999% | +$400,000 | |||||
| D | 2026-02-12 | COCH | Envoy Medical, Inc. | Lucas Brent T. | CEO | P - Purchase | $0.40 | +62,500 | 297,090 | +27% | +$25,000 | |||||
| D | 2026-02-12 | COCH | Envoy Medical, Inc. | Kantor Susan | Dir | P - Purchase | $0.40 | +96,150 | 174,037 | +123% | +$38,460 | |||||
| D | 2026-02-12 | COCH | Envoy Medical, Inc. | Potashnick Robert | Interim CFO | P - Purchase | $0.40 | +212,500 | 212,500 | New | +$85,000 | |||||
| D | 2026-02-12 | COCH | Envoy Medical, Inc. | Patel Mona Chetan | Dir | P - Purchase | $0.40 | +312,500 | 332,500 | >999% | +$125,000 | |||||
2026-02-06 | COCP | Cocrystal Pharma, Inc. | Frost Phillip Md Et Al | Dir, 10% | P - Purchase | $0.95 | +50,000 | 1,915,651 | +3% | +$47,280 | ||||||
2026-01-23 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.50 | +90,325 | 8,182,120 | +1% | +$45,000 | ||||||
2026-02-11 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.41 | +291,262 | 8,473,382 | +4% | +$120,000 | ||||||
2026-02-12 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.37 | +388,532 | 8,861,914 | +5% | +$145,000 | ||||||
2026-02-10 | COTY | Coty Inc. | Mercier Laurent | CFO | P - Purchase | $2.65 | +5,000 | 500,031 | +1% | +$13,250 | ||||||
| M | 2026-01-28 | ELUT | Elutia Inc. | Neels Guido J | Dir | P - Purchase | $1.06 | +30,000 | 98,750 | +44% | +$31,800 | |||||
2026-01-30 | ELUT | Elutia Inc. | Neels Guido J | Dir | P - Purchase | $1.04 | +20,000 | 118,750 | +20% | +$20,800 | ||||||
2026-01-30 | ELUT | Elutia Inc. | Rakin Kevin | Dir, 10% | P - Purchase | $1.06 | +70,000 | 5,225,098 | +1% | +$74,200 | ||||||
| M | 2026-01-28 | EMPD | Empery Digital Inc. | Atg Capital Opportunities Fund LP | 10% | P - Purchase | $4.94 | +428,626 | 3,808,855 | +13% | +$2,115,728 | |||||
| M | 2026-02-02 | EMPD | Empery Digital Inc. | Atg Capital Opportunities Fund LP | 10% | P - Purchase | $4.68 | +691,145 | 4,500,000 | +18% | +$3,232,479 | |||||
| AM | 2026-01-28 | EMPD | Empery Digital Inc. | Atg Capital Management LP | 10% | P - Purchase | $4.94 | +428,626 | 3,808,855 | +13% | +$2,115,728 | |||||
| AM | 2026-02-02 | EMPD | Empery Digital Inc. | Atg Capital Management LP | 10% | P - Purchase | $4.68 | +691,145 | 4,500,000 | +18% | +$3,232,479 | |||||
2026-02-09 | ENTX | Entera Bio Ltd. | Ellis Sean | Dir | P - Purchase | $1.24 | +18,000 | 178,098 | +11% | +$22,320 | ||||||
2026-02-09 | ENTX | Entera Bio Ltd. | Rubin Steven D | Dir | P - Purchase | $1.20 | +10,000 | 10,000 | New | +$12,000 | ||||||
2026-02-10 | ENTX | Entera Bio Ltd. | Germano Geno J | Dir | P - Purchase | $1.49 | +20,000 | 0 | -100% | +$29,800 | ||||||
2026-02-10 | ENTX | Entera Bio Ltd. | Taitel Haya | Dir | P - Purchase | $1.48 | +7,500 | 0 | -100% | +$11,100 | ||||||
| D | 2026-02-10 | ERNA | Ernexa Therapeutics Inc. | Cherington Charles | 10% | P - Purchase | $0.50 | +4,000,000 | 6,779,440 | +144% | +$2,000,000 | |||||
2026-02-02 | FEAM | 5E Advanced Materials, Inc. | Bep Special Situations IV LLC | Dir, 10% | P - Purchase | $2.00 | +4,000,000 | 12,130,997 | +49% | +$8,000,000 | ||||||
2026-01-14 | FEED | Envue Medical, Inc. | Glibert Christian Michael | 10% | P - Purchase | $2.67 | +240,000 | 240,000 | New | +$640,800 | ||||||
| D | 2026-02-10 | FIEE | Fiee, Inc. | Elements Corporate Services Ltd | 10% | P - Purchase | $1.29 | +2,138,181 | 3,119,830 | +218% | +$2,758,253 | |||||
2026-02-17 | GGT | Gabelli Multimedia Trust Inc. | Bogan Elizabeth C | Dir | P - Purchase | $4.05 | +2,700 | 2,700 | New | +$10,922 | ||||||
| M | 2026-02-18 | GNSS | Genasys Inc. | Dodd William H | Dir | P - Purchase | $1.98 | +25,457 | 129,163 | +25% | +$50,405 | |||||
2026-02-09 | LAW | Cs Disco, Inc. | Offerdahl James | Dir | P - Purchase | $3.99 | +3,000 | 223,652 | +1% | +$11,970 | ||||||
2026-02-05 | LEE | Lee Enterprises, Inc | Quint Digital Ltd | 10% | P - Purchase | $3.25 | +2,451,346 | 3,214,346 | +321% | +$7,966,875 | ||||||
2026-01-21 | LNZA | Lanzatech Global, Inc. | Guardians of New Zealand Superannuation | 10% | P - Purchase | $4.43 | +969,858 | 1,302,492 | +292% | +$4,300,000 | ||||||
2026-02-09 | LSAK | Lesaka Technologies Inc | Mazanderani Ali | Exec COB | P - Purchase | $4.36 | +91,423 | 2,416,538 | +4% | +$398,604 | ||||||
2026-02-02 | LXRX | Lexicon Pharmaceuticals, Inc. | Invus Global Management, LLC | Dir, 10% | P - Purchase | $1.30 | +1,538,462 | 44,145,189 | +4% | +$2,000,001 | ||||||
| M | 2026-02-13 | LXRX | Lexicon Pharmaceuticals, Inc. | Debbane Raymond | Dir | P - Purchase | $1.31 | +268,497 | 51,408,909 | +1% | +$352,889 | |||||
2026-01-26 | MIGI | Mawson Infrastructure Group Inc. | Endeavor Blockchain, LLC | 10% | P - Purchase | $4.84 | +60,000 | 1,545,297 | +4% | +$290,400 | ||||||
2026-01-28 | MIGI | Mawson Infrastructure Group Inc. | Endeavor Blockchain, LLC | 10% | P - Purchase | $4.57 | +42,100 | 87,397 | +93% | +$192,502 | ||||||
| M | 2026-02-17 | NAII | Natural Alternatives International Inc | Ledoux Mark A | CEO, COB, 10% | P - Purchase | $2.58 | +4,500 | 721,542 | +1% | +$11,604 | |||||
2026-02-13 | NRDE | Nu Ride Inc. | Wartell Michael J. | Dir | P - Purchase | $1.59 | +6,548 | 227,081 | +3% | +$10,411 | ||||||
| M | 2026-02-11 | NRX | Neuraxis, Inc | Hannasch Brian | 10% | P - Purchase | $4.79 | +80,000 | 1,211,522 | +7% | +$382,800 | |||||
2026-02-18 | NTWK | Netsol Technologies Inc | Ghauri Najeeb | CEO | P - Purchase | $3.25 | +6,000 | 937,002 | +1% | +$19,500 | ||||||
2026-02-13 | NWPP | New Peoples Bankshares Inc | White Blaine Scott | Dir, 10% | P - Purchase | $3.84 | +11,725 | 5,645,381 | 0% | +$45,001 | ||||||
2026-02-13 | NWWP | New Peoples Bankshares Inc | Cox John D | Dir | P - Purchase | $3.84 | +11,724 | 857,555 | +1% | +$44,997 | ||||||
| M | 2026-02-11 | ONCY | Oncolytics Biotech Inc | Kelly Jared | CEO | P - Purchase | $0.84 | +35,100 | 109,000 | +47% | +$29,521 | |||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Look Kirk | CFO | P - Purchase | $0.84 | +12,000 | 287,515 | +4% | +$10,104 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Pisano Wayne | Dir | P - Purchase | $0.84 | +30,000 | 492,414 | +6% | +$25,338 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Heineman Thomas Charles | Chief Medical Officer | P - Purchase | $0.83 | +12,132 | 282,818 | +4% | +$10,033 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Brown Deborah Margaret | Dir | P - Purchase | $0.85 | +25,000 | 109,851 | +29% | +$21,240 | ||||||
| M | 2026-02-11 | ONCY | Oncolytics Biotech Inc | Seizinger Bernd R. | Dir | P - Purchase | $0.83 | +100,000 | 566,991 | +21% | +$83,454 | |||||
2026-02-11 | ONCY | Oncolytics Biotech Inc | Aromando Andrew | Chief Business Officer | P - Purchase | $0.86 | +29,600 | 55,100 | +116% | +$25,418 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Andrews Patricia S | Dir | P - Purchase | $0.86 | +35,400 | 78,128 | +83% | +$30,292 | ||||||
2026-02-11 | PSEC | Prospect Capital Corp | Eliasek M Grier | COO | P - Purchase | $2.92 | +942,800 | 3,443,930 | +38% | +$2,749,770 | ||||||
| M | 2026-02-10 | RBBN | Ribbon Communications Inc. | McClelland Bruce William | Pres, CEO | P - Purchase | $2.01 | +37,000 | 1,516,164 | +3% | +$74,307 | |||||
2026-02-11 | SLQT | Selectquote, Inc. | Grant Robert Clay | Pres | P - Purchase | $0.88 | +118,901 | 5,525,804 | +2% | +$105,024 | ||||||
| M | 2026-01-30 | SNES | Senestech, Inc. | Glenbrook Capital Management | 10% | P - Purchase | $1.96 | +48,138 | 1,144,831 | +4% | +$94,524 | |||||
| M | 2026-02-04 | SNES | Senestech, Inc. | Glenbrook Capital Management | 10% | P - Purchase | $1.81 | +8,569 | 1,201,824 | +1% | +$15,480 | |||||
| M | 2026-02-11 | SNES | Senestech, Inc. | Glenbrook Capital Management | 10% | P - Purchase | $1.81 | +31,346 | 1,244,054 | +3% | +$56,667 | |||||
| M | 2026-02-17 | SNES | Senestech, Inc. | Glenbrook Capital Management | 10% | P - Purchase | $2.34 | +85,901 | 1,363,328 | +7% | +$200,635 | |||||
2026-01-23 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Dir | P - Purchase | $3.13 | +41,000 | 48,000 | +586% | +$128,486 | ||||||
2026-01-23 | STEX | Streamex Corp. | Williams Mitchell Young | Chief Investment Officer | P - Purchase | $3.03 | +51,511 | 1,051,511 | +5% | +$155,852 | ||||||
2026-01-26 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Dir, 10% | P - Purchase | $3.30 | +23,000 | 71,000 | +48% | +$75,900 | ||||||
2026-01-27 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Dir, 10% | P - Purchase | $3.12 | +5,500 | 76,500 | +8% | +$17,160 | ||||||
2026-01-23 | STEX | Streamex Corp. | Giustra Frank | 10% | P - Purchase | $3.00 | +1,000,000 | 1,178,205 | +561% | +$3,000,000 | ||||||
2026-02-03 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Dir, 10% | P - Purchase | $3.06 | +23,500 | 102,500 | +30% | +$71,910 | ||||||
2026-02-04 | STEX | Streamex Corp. | Giustra Frank | 10% | P - Purchase | $3.17 | +100,000 | 1,278,205 | +8% | +$317,000 | ||||||
2026-02-18 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Exec COB, 10% | P - Purchase | $2.50 | +20,000 | 122,500 | +20% | +$50,000 | ||||||
| AD | 2026-02-04 | STQN | Strategic Acquisitions Inc /Nv/ | Oshea John P | Pres, 10% | P - Purchase | $0.00 | +30,000,000 | 30,151,800 | >999% | +$30,000 | |||||
| D | 2026-02-18 | STQN | Strategic Acquisitions Inc /Nv/ | O'Shea Jennifer L | Dir, 10% | P - Purchase | $0.00 | +10,000,000 | 10,018,565 | >999% | +$10,000 | |||||
2026-01-27 | THM | International Tower Hill Mines Ltd | Paulson & Co. Inc. | 10% | P - Purchase | $2.22 | +18,018,018 | 88,257,406 | +26% | +$40,000,000 | ||||||
2026-01-27 | THM | International Tower Hill Mines Ltd | Electrum Global Holdings L.P. | 10% | P - Purchase | $2.22 | +3,153,153 | 31,918,825 | +11% | +$7,000,000 | ||||||
| M | 2026-01-28 | THM | International Tower Hill Mines Ltd | Paulson & Co. Inc. | 10% | P - Purchase | $2.22 | +11,315,632 | 99,573,038 | +13% | +$25,120,703 | |||||
| D | 2026-02-12 | TLPH | Talphera, Inc. | Angotti Vincent J. | CEO | P - Purchase | $0.81 | +105,364 | 577,395 | +22% | +$85,587 | |||||
| D | 2026-02-12 | TLPH | Talphera, Inc. | Aslam Shakil | Chief Medical Officer | P - Purchase | $0.81 | +35,000 | 83,178 | +73% | +$28,431 | |||||
| D | 2026-02-12 | TLPH | Talphera, Inc. | Dasu Badri N | Chief Engineering Officer | P - Purchase | $0.81 | +35,000 | 73,884 | +90% | +$28,431 | |||||
| D | 2026-02-12 | TLPH | Talphera, Inc. | Asadorian Raffi | CFO | P - Purchase | $0.81 | +45,000 | 179,579 | +33% | +$36,554 | |||||
| M | 2026-02-11 | TSI | Tcw Strategic Income Fund Inc | McMillan Peter | Dir | P - Purchase | $4.73 | +190,000 | 200,000 | >999% | +$898,784 | |||||
2026-02-13 | TSI | Tcw Strategic Income Fund Inc | McMillan Peter | Dir | P - Purchase | $4.71 | +17,390 | 217,390 | +9% | +$81,907 | ||||||
2026-02-18 | TSI | Tcw Strategic Income Fund Inc | McMillan Peter | Dir | P - Purchase | $4.70 | +32,610 | 250,000 | +15% | +$153,267 | ||||||
2026-02-20 | TSI | Tcw Strategic Income Fund Inc | McMillan Peter | Dir | P - Purchase | $4.64 | +50,000 | 300,000 | +20% | +$232,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |